Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 01:00 ET | Source: Idorsia Pharmaceuticals Ltd

Idorsia initiates a proof-of-concept trial with its oral first-in-class selective CCR6 antagonist

The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications Allschwil, Switzerland – January 6, 2026Idorsia...
January 06, 2026 01:00 ET | Source: Sika AG

SIKA ERHÄLT DEN DEUTSCHEN NACHHALTIGKEITSPREIS 2026 FÜR IHRE TECHNOLOGIEFÜHRERSCHAFT

SIKA ERHÄLT DEN DEUTSCHEN NACHHALTIGKEITSPREIS 2026 FÜR IHRE TECHNOLOGIEFÜHRERSCHAFTFür ihr SikaBaffle® AutoStack-System ist Sika mit dem renommierten Deutschen Nachhaltigkeitspreis ausgezeichnet...
January 06, 2026 01:00 ET | Source: Sika AG

SIKA RECEIVES THE 2026 GERMAN SUSTAINABILITY AWARD FOR ITS TECHNOLOGY LEADERSHIP

SIKA RECEIVES THE 2026 GERMAN SUSTAINABILITY AWARD FOR ITS TECHNOLOGY LEADERSHIPSika has received the renowned German Sustainability Award for its SikaBaffle® AutoStack system. The jury recognized the...
January 05, 2026 11:45 ET | Source: Idorsia Pharmaceuticals Ltd

Idorsia’s daridorexant in women during menopausal transition age with insomnia

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition ageBrigham and Women’s Hospital...
January 05, 2026 01:00 ET | Source: Idorsia Pharmaceuticals Ltd

Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral...
December 29, 2025 16:15 ET | Source: 21Shares

21shares Announces Distribution Dates on TETH

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced distribution dates for the 21shares...
December 29, 2025 16:05 ET | Source: Wisekey International Holding Ltd.

WISeKey International Holding AG (Nasdaq: WKEY) and Columbus Acquisition Corp. (Nasdaq: COLA) Announce Confidential Submission of Draft Registration Statement on Form F-4 in Connection with Proposed Business Combination

Canton of Zug, Switzerland and Singapore – December 29, 2025 - WISeKey International Holding AG (Nasdaq: WKEY) (“WISeKey”) , a global leader in cybersecurity, digital identity, and IoT solutions...
December 29, 2025 03:00 ET | Source: GAM Holding AG

PRESS RELEASE: Portfolio managers of three GAM-managed special situations funds publish open letter on Yutaka Giken tender offer

GAM Fund managers publish open letter on Yutaka Giken tender offer, citing low premium and net-cash undervaluation, urging transparency and a higher price.
December 22, 2025 02:30 ET | Source: ArcelorMittal S.A.

ArcelorMittal expands its portfolio of renewable energy projects

Three new projects in India will bring the Company’s global renewable energy capacity to 3.3GW 22 December 2025, 08:30 CET ArcelorMittal (‘the Company’) today announces three new renewable energy...
December 22, 2025 01:00 ET | Source: Wisekey International Holding Ltd.

WISeKey Issues Year-End CEO Letter to Shareholders

Geneva, Switzerland, December 22, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today issued a Letter to...